ADMA· Adma Biologics Inc.
Insider buys/sells · last 6 mo · open market only
| Transactions | Total $ | |
|---|---|---|
| Buys | 2 | $217K |
| Sells | 5 | $814K |
Quarterly ownership history
Last 5 quarters
ADMA Financials
Live via yfinance — refreshed daily.
Valuation
Market capitalization$1.9B
Enterprise value$43.6B
EV / EBITDA (TTM)203.15
P/E ratio (TTM)12.01
Forward P/E7.73
P/S ratio3.71
P/B ratio4.07
PEG ratio—
Cash Flow
Operating cash flow (TTM)$128M
Free cash flow (TTM)$58M
Total cash$55.9B
Total debt$97.7B
Debt / equity110.67
Current ratio6.95
Income Statement
Total revenue (TTM)$510M
Revenue per share (TTM)2.14
Gross profit (TTM)$312M
EBITDA (TTM)$215M
Net income (TTM)$165M
EPS diluted (TTM)0.68
Shares outstanding231,772,715
Float shares226,771,060
Profitability
Gross margin61.27%
Operating margin-123.39%
EBITDA margin42.13%
Net margin32.43%
Efficiency
Return on assets (TTM)21.99%
Return on equity (TTM)43.30%
Price History
Current price$8.17
52 Week high$22.37
52 Week low$7.21
50 day average$11.90
200 day average$15.64
Average volume (10 day)9,226,390
1-year beta0.82
1-year price target$16.75
Dividends
Dividend yield—
Dividend rate (annual)—
Payout ratio0.00%
Fundamentals are sourced from yfinance and refreshed daily. Last updated May 10, 2026, 5:35 PM. Empty cells (—) mean yfinance doesn't have that field for this ticker (common for ADRs, recent IPOs, or non-applicable ratios).
Real-time alerts. We'll let you know when a whale you follow files a new 13F, or a stock you follow has insider activity. No weekly digest.
whalstreet
★ WatchlistData from SEC EDGAR · whalstreet.com